Enkephalin degradation stimulated by captopril

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Enkephalins are endogenous opioid peptides involved in pain modulation and other neurological functions.
• Brain aminopeptidase plays a key role in the metabolism of enkephalins.
• Understanding factors affecting enkephalin degradation is crucial for neurological research.

Purpose of the Study:

• To investigate the effects of captopril and other compounds on the degradation rates of Met- and Leu-enkephalin by brain aminopeptidase.
• To characterize the influence of specific substances on enkephalinase activity.

Main Methods:

• Measurement of Met- and Leu-enkephalin degradation rates using UV absorption.
• High-performance liquid chromatography (HPLC) for separation and quantification.
• Assay of enzyme activity in the presence of captopril, Pro-His-Pro-NH2, histidine, and histamine.

Main Results:

• Captopril (SQ 14,225) stimulated brain aminopeptidase activity, with a more pronounced effect on Met-enkephalin degradation compared to Leu-enkephalin.
• Pro-His-Pro-NH2, histidine, and histamine were found to be potent stimulators of enkephalin aminopeptidase activity, exceeding captopril's effect.
• The stimulatory effect of captopril was not solely dependent on its sulfhydryl group.
• Captopril did not alter the pH optimum of the enzyme and enhanced enkephalin degradation within a temperature range of 25–50°C.

Conclusions:

• Specific compounds, including captopril, Pro-His-Pro-NH2, histidine, and histamine, significantly modulate brain aminopeptidase activity.
• These findings highlight the complex regulation of enkephalin metabolism by various endogenous and exogenous substances.
• Further research into these modulators could offer insights into therapeutic strategies targeting the enkephalinergic system.